All articles by Staff Writer
Staff Writer
GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents
GE HealthCare (Nasdaq: GEHC) today announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA)—part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS)—to develop and obtain regulatory clearance for next-generation advanced point-of-care ultrasound technology with new artificial intelligence (AI) applications. Technology resulting from this jointly funded program will help healthcare professionals at all skill levels rapidly diagnose and provide timely treatment for patients with lung pathologies and traumatic injuries to the abdomen, chest and head.
Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
ORi to Be Launched in the U.S. at ANESTHESIOLOGY 2023 This Weekend
Cirdan Ltd secures £2.3m to expand operations in New Funding Round Led by Kernel Capital
Lisburn based Cirdan, is a global leader in digital pathology with clients in over 150 laboratories and hospitals across 20 countries and 6 continents. The Company is growing its revenues with expected 80%+ year on year growth in 2024. Cirdan has successfully secured £2.3m in new funding to expand business operations with the creation of up to 25 new jobs ahead of new contract wins. The investment was led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI). Other investors include Clarendon Fund Managers and high net worth private investors.
MEDICA 2023: KERN exhibits digital networkable balances in Hall 9
KERN & SOHN GmbH is presenting the new products in its medical technology range at MEDICA in Düsseldorf on Stand B25 in Hall 9. From 13 to 16 November, the family business from Southern Germany will exhibit, amongst other products, the KERN Premium Line, a new product range of digital networkable balances, at the trade fair.
UPS Healthcare launches industry-leading reverse logistics service in Europe
Today, UPS Healthcare has launched UPS® Pickup Point locations for laboratory customers across key European healthcare markets including the U.K., Germany, Italy, France, and Spain.
When digital transformation hits the reality of healthcare at full speed – Chat GPT can do medicine
MEDICA HEALTH IT FORUM shines a light on general trends within digitalisation and their potential for application in healthcare
AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product
Noul Co., Ltd., (376930.KR), an Artificial Intelligence (AI) based blood and cancer diagnostic platform company, has newly introduced ‘miLab™ Cartridge CER’, a cervical cell analysis product at the International Federation of Gynecology and Obstetrics 2023.
How RFID could help address healthcare inefficiency
The misplacement and loss of equipment and diagnostic samples, among other resources, results in hours of wasted time in the clinic that can have a real impact on patient care. Richard Salmons – Solution Specialist – Location Solutions at Zebra Technologies Corporation EMEA Healthcare Practice speaks of the difficulties these day-to-day occurrences lead to in healthcare, and the solutions his organisation believes might help address them.
QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in various epidemiological studies to be positive in more than 90% of the world’s population and is a significant pathogen in organ transplant recipients.
Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe
Featured presentations highlight how Seven Bridges delivers flexibility, compatibility and collaboration in support of key initiatives like AI/ML in drug discovery and neoantigen research